Page 160 - 2021_09-Haematologica-web

M. Germeshausen and M, Ballmaier
93(6):943-944.
10. Giampietro PF, Verlander PC, Davis JG,
Auerbach AD. Diagnosis of Fanconi anemia in patients without congenital malforma- tions: an international Fanconi Anemia Registry Study. Am J Med Genet. 1997; 68(1):58-61.
11. Germeshausen M, Ancliff P, Estrada J, et al. MECOM-associated syndrome: a heteroge- neous inherited bone marrow failure syn- drome with amegakaryocytic thrombocy- topenia. Blood Adv. 2018;2(6):586-596.
12. Christensen RD, Wiedmeier SE, Yaish HM. A neonate with congenital amegakaryocytic thrombocytopenia associated with a chro- mosomal microdeletion at 21q22.11 includ- ing the gene RUNX1. J Perinatol. 2013;33 (3):242-244.
13. Geddis AE. Congenital amegakaryocytic thrombocytopenia. Pediatr Blood Cancer. 2011;57(2):199-203.
14. King S, Germeshausen M, Strauss G, Welte K, Ballmaier M. Congenital amegakaryocytic thrombocytopenia: a retrospective clinical analysis of 20 patients. Br J Haematol. 2005;131(5):636-644.
15. Germeshausen M, Ballmaier M, Welte K. MPL mutations in 23 patients suffering from congenital amegakaryocytic thrombocy- topenia: the type of mutation predicts the course of the disease. Hum Mutat. 2006;27(3):296.
16. Stoddart MT, Connor P, Germeshausen M, Ballmaier M, Steward CG. Congenital amegakaryocytic thrombocytopenia (CAMT) presenting as severe pancytopenia in the first month of life. Pediatr Blood Cancer. 2013;60(9):E94-96.
17. Ok Bozkaya I, Yarali N, Isik P, Unsal Sac R, Tavil B, Tunc B. Severe clinical course in a patient with congenital amegakaryocytic thrombocytopenia due to a missense muta- tion of the c-MPL gene. Turk J Haematol. 2015;32(2):172-174.
18. Choi Y, Chan AP. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics. 2015;31(16):2745-2747.
19. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4(7):1073-1081.
20. Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7 (4):248-249.
21. Schwarz JM, Cooper DN, Schuelke M, Seelow D. MutationTaster2: mutation pre- diction for the deep-sequencing age. Nat Methods. 2014;11(4):361-362.
22. Reese MG, Eeckman FH, Kulp D, Haussler D. Improved splice site detection in Genie. J Comput Biol. 1997;4(3):311-323.
23. Yeo G, Burge CB. Maximum entropy model- ing of short sequence motifs with applica- tions to RNA splicing signals. J Comput Biol. 2004;11(2-3):377-394.
24.Desmet FO, Hamroun D, Lalande M, Collod-Beroud G, Claustres M, Beroud C. Human Splicing Finder: an online bioinfor- matics tool to predict splicing signals. Nucleic Acids Res. 2009;37(9):e67.
25. Ballmaier M, Holter W, Germeshausen M. Flow cytometric detection of MPL (CD110) as a diagnostic tool for differentiation of con- genital thrombocytopenias. Haematologica. 2015;100(9):e341-344.
26. Gandhi MJ, Pendergrass TW, Cummings CC, Ihara K, Blau CA, Drachman JG. Congenital amegakaryocytic thrombocy- topenia in three siblings: molecular analysis of atypical clinical presentation. Exp Hematol. 2005;33(10):1215-1221.
27.Varghese LN, Zhang JG, Young SN, et al. Functional characterization of c-Mpl ectodomain mutations that underlie congen- ital amegakaryocytic thrombocytopenia. Growth Factors. 2014;32(1):18-26.
28.Jalas C, Anderson SL, Laufer T, et al. A founder mutation in the MPL gene causes congenital amegakaryocytic thrombocy- topenia (CAMT) in the Ashkenazi Jewish population. Blood Cells Mol Dis. 2011;47(1):79-83.
29. Alter BP. Diagnosis, genetics, and manage- ment of inherited bone marrow failure syn- dromes. Hematology Am Soc Hematol Educ Program. 2007;2007:29-39.
30. Steele M, Hitzler J, Doyle JJ, et al. Reduced intensity hematopoietic stem-cell transplan- tation across human leukocyte antigen barri- ers in a patient with congenital amegakary- ocytic thrombocytopenia and monosomy 7. Pediatr Blood Cancer. 2005;45(2):212-216.
31. Tuller T, Waldman YY, Kupiec M, Ruppin E. Translation efficiency is determined by both codon bias and folding energy. Proc Natl Acad Sci U S A. 2010;107(8):3645-3650.
32.Dokal I, Vulliamy T. Inherited aplastic anaemias/bone marrow failure syndromes. Blood Rev. 2008;22(3):141-153.
33.WeinzierlEP,ArberDA.Thedifferential diagnosis and bone marrow evaluation of new-onset pancytopenia. Am J Clin Pathol. 2013;139(1):9-29.
34. Rivers A, Slayton WB. Congenital cytopenias and bone marrow failure syndromes. Semin Perinatol. 2009;33(1):20-28.
35. Geddis AE. Inherited thrombocytopenia: Congenital amegakaryocytic thrombocy- topenia and thrombocytopenia with absent radii. Semin Hematol. 2006;43(3):196-203. Sola-Visner M. Platelets in the neonatal peri- od: developmental differences in platelet production, function, and hemostasis and the potential impact of therapies. Hematology Am Soc Hematol Educ Program. 2012;2012:506-511.
37.Lorenz V, Ramsey H, Liu ZJ, et al. Developmental stage-specific manifestations of absent TPO/c-MPL signalling in newborn mice. Thromb Haemost. 2017;117(12):2322- 2333.
38. Baker-Groberg SM, Lattimore S, Recht M, McCarty OJ, Haley KM. Assessment of neonatal platelet adhesion, activation, and aggregation. J Thromb Haemost. 2016;14(4): 815-827.
39. Bunting S, Widmer R, Lipari T, et al. Normal platelets and megakayocytes are produced in vivo in the absence of thrombopoietin. Blood. 1997;90(9):3423-3429.
40. Ballmaier M, Germeshausen M, Krukemeier S, Welte K. Thrombopoietin is essential for the maintenance of normal hematopoiesis in humans: development of aplastic anemia in patients with congenital amegakaryocytic thrombocytopenia. Ann N Y Acad Sci. 2003;996:17-25.
41.Steinberg O, Gilad G, Dgany O, et al. Congenital amegakaryocytic thrombocy- topenia-3 novel c-MPL mutations and their phenotypic correlations. J Pediatr Hematol Oncol. 2007;29(12):822-825.
42. Dame C, Wolber EM, Freitag P, Hofmann D, Bartmann P, Fandrey J. Thrombopoietin gene expression in the developing human central nervous system. Brain Res Dev Brain Res. 2003;143(2):217-223.
43. Ehrenreich H, Hasselblatt M, Knerlich F, et al. A hematopoietic growth factor, thrombopoi- etin, has a proapoptotic role in the brain. Proc Natl Acad Sci U S A. 2005;102(3):862-867.
44. Ivanova A, Wuerfel J, Zhang J, Hoffmann O, Ballmaier M, Dame C. Expression pattern of the thrombopoietin receptor (Mpl) in the murine central nervous system. BMC Dev Biol. 2010;10:77.
45.Hoffmann O, Rung O, Im AR, et al. Thrombopoietin Contributes to Neuronal Damage in Experimental Bacterial Meningitis. Infect Immun. 2011;79(2):928- 936
46. Castro Conde JR, Martinez ED, Rodriguez RC, Rodriguez De Hoyos AL. CNS siderosis and dandy-walker variant after neonatal alloimmune thrombocytopenia. Pediatr Neurol. 2005;32(5):346-349.
47. Goto T, Kakita H, Takasu M, et al. A rare case of fetal extensive intracranial hemor- rhage and whole-cerebral hypoplasia due to latent maternal vitamin K deficiency. J Neonatal Perinatal Med. 2018;11(2):191- 194.
48. Marszal E, Jamroz E, Pilch J, Kluczewska E, Jablecka-Deja H, Krawczyk R. Agenesis of corpus callosum: clinical description and eti- ology. J Child Neurol. 2000;15(6):401-405.
49.O'KeefeM,Kafil-HussainN,FlitcroftI, Lanigan B. Ocular significance of intraven- tricular haemorrhage in premature infants. Br J Ophthalmol. 2001;85(3):357-359.
50. Tsilou ET, Giri N, Weinstein S, Mueller C, Savage SA, Alter BP. Ocular and orbital man- ifestations of the inherited bone marrow fail- ure syndromes: Fanconi anemia and dysker- atosis congenita. Ophthalmology. 2010;117 (3):615-622.
51. Yıldırım AT, Günes BT, Oymak Y, et al. Congenital amegakaryocytic thrombocy- topenia: three case reports from patients with different clinical diagnoses and somatic abnormalities. Blood Coagul Fibrinolysis. 2015;26(3):337-341.
52.Zlotogora J. What is the birth defect risk associated with consanguineous marriages? Am J Med Genet. 2002;109(1):70-71.
53. Maserati E, Panarello C, Morerio C, et al. Clonal chromosome anomalies and propen- sity to myeloid malignancies in congenital amegakaryocytic thrombocytopenia (OMIM 604498). Haematologica. 2008;93(8):1271- 1273.
54. Matatall KA, Jeong M, Chen S, et al. Chronic infection depletes hematopoietic stem cells through stress-induced terminal differentia- tion. Cell Rep. 2016;17(10):2584-2595.
55. Walne AJ, Dokal A, Plagnol V, et al. Exome sequencing identifies MPL as a causative gene in familial aplastic anemia. Haematologica. 2012;97(4):524-528.
56.Savoia A, Dufour C, Locatelli F, et al. Congenital amegakaryocytic thrombocy- topenia: clinical and biological consequences of five novel mutations. Haematologica. 2007;92(9):1186-1193.
57.Kohler S, Carmody L, Vasilevsky N, et al. Expansion of the human phenotype ontol- ogy (HPO) knowledge base and resources. Nucleic Acids Res. 2019;47(D1):D1018- D1027.
36.
2448
haematologica | 2021; 106(9)